The Summer Investor Capital Expo returned to Seattle's Washington Athletic Club on August 19 and 20, bringing together early-stage entrepreneurs, angel investors, and industry experts for two days of pitches, insights, and networking — with the event also livestreamed on Zoom for those joining remotely.
As always, the highlight of the Expo was the Most Valued Company award, decided by the attending investors who cast their votes for the companies that most impressed them in terms of innovation, impact, and growth potential. This year's voting produced a clear standout, along with two runners-up tackling problems in dental health, brain disease, pediatric medicine, and housing. Here's a closer look at all four.
Winner: Mussel Polymers
For the third time, Mussel Polymers Inc. (MPI) took home the Most Valued Company Award—previously winning at the Summer Expo 2025 and Rockies Expo 2026. MPI develops, manufactures, and sells the first catechol polymers for biomedical, defense, and industrial applications.
With more than 4,000 U.S. patents issued around the use of catechol polymers, MPI is the first and only commercial source for these solutions in the biomedical and industrial sectors. Its innovations include a potential permanent treatment for tooth sensitivity by causing bone to precipitate on teeth, as well as underwater-applied coatings and adhesives.
Investors were clearly impressed by MPI’s cutting-edge technology, extensive intellectual property, and potential to address major problems across multiple markets.
Runner-Up: Sinaptica Therapeutics
Sinaptica Therapeutics is tackling one of healthcare’s most significant challenges: Alzheimer’s disease. Its approach combines TMS, EEG, and neuronavigation to deliver personalized, noninvasive neuromodulation to the brain’s Default Mode Network—the key memory network implicated in Alzheimer’s disease.
By stimulating the DMN, Sinaptica aims to induce neuroplasticity, restore synaptic function, and promote network stability. The company’s approach stood out to investors for its focus on a massive and growing healthcare challenge, while offering a noninvasive and personalized pathway to treatment.
The combination of advanced neuroscience, precision technology, and a significant unmet medical need earned Sinaptica the Runner-Up position.
Second Runner-Ups: OtoNexus Medical Technologies & Azure Printed Homes
OtoNexus Medical Technologies is addressing a common but costly challenge in pediatric healthcare: accurately diagnosing middle ear infections. Current diagnostic tools are only about 50% accurate, while antibiotics are prescribed in approximately 85% of cases despite being appropriate in only around 15%.
OtoNexus has developed a handheld device designed to identify both the presence and type of middle ear infection, delivering results in just two seconds. The technology could help clinicians determine when antibiotics are actually needed, potentially reducing unnecessary prescriptions while improving patient care.
Investors were impressed by the simplicity of OtoNexus’ solution and its potential to create value across patients, clinicians, hospitals, and insurance providers.
Azure Printed Homes is taking on the U.S. housing shortage with a radically different approach to construction. The company develops AI-enabled modular housing factories that combine 3D printing, robotics, automation, and light-gauge steel manufacturing to build homes faster and at lower cost.
Rather than relying on traditional construction sites, Azure produces homes in automated factories, reducing labor requirements and material waste while creating more predictable quality and delivery timelines.
Investors were drawn to the company’s ability to apply advanced manufacturing technology to a massive real-world problem. Its combination of automation, scalability, cost efficiency, and sustainability demonstrated how technology can help reshape one of the world’s most essential industries.
Closing Thoughts
The four Most Valued Company Award winners represent very different industries and approaches, but they share a common thread: they are solving significant problems with differentiated solutions and the potential to create meaningful impact at scale.
From Mussel Polymers’ breakthrough materials technology to Sinaptica’s approach to Alzheimer’s, OtoNexus’ diagnostic innovation, and Azure Printed Homes’ transformation of housing construction, these companies demonstrated why investors continue to look beyond ideas and toward businesses capable of changing industries.
The investor votes at the Summer Investor Capital Expo 2026 are a strong recognition of that potential—and a reminder that the most compelling companies are often those tackling the problems that matter most.